Cellular overexpression of heme oxygenase-1 up-regulates p21 and confers resistance to apoptosis  by Inguaggiato, Paola et al.
Kidney International, Vol. 60 (2001), pp. 2181–2191
Cellular overexpression of heme oxygenase-1 up-regulates
p21 and confers resistance to apoptosis
PAOLA INGUAGGIATO, LUIS GONZALEZ-MICHACA, ANTHONY J. CROATT, JILL J. HAGGARD,
JAWED ALAM, and KARL A. NATH
Division of Nephrology, Mayo Clinic/Foundation, Rochester, Minnesota, and Department of Molecular Genetics, Alton
Ochsner Medical Foundation, New Orleans, Louisiana, USA
HO-1 to markedly influence the cell cycle in renal epithelialCellular overexpression of heme oxygenase-1 up-regulates p21
cells. In light of the profound importance of the cell cycle asand confers resistance to apoptosis.
a determinant of cell fate, we speculate that the inductive effectBackground. Induction of heme oxygenase-1 (HO-1) pro-
of HO-1 on p21 and the attendant inhibitory effect on the celltects against diverse insults in the kidney and other tissues.
cycle provide a hitherto unsuspected mechanism underlyingWe examined the effect of overexpression of HO-1 on cell
the cytoprotective actions of HO-1.growth, expression of p21, and susceptibility to apoptosis.
Methods. LLC-PK1 cells were genetically engineered to ex-
hibit stable overexpression of HO-1. The effects of such overex-
pression on cell growth, the cell cycle, and the cell cycle-inhibi-
Enzymes that possess heme oxygenase (HO) activitytory protein, p21, were assessed; additionally, the susceptibility
provide the principal degradative mechanism for the dis-of these HO-1 overexpressing cells to apoptosis induced by
three different stimuli (TNF-/cycloheximide, staurosporine, posal of heme in tissues [1–3]. These enzymes facilitate
or serum deprivation) was evaluated by such methods as the the opening of the heme ring and its conversion to bili-
quantitation of caspase-3 activity, phase contrast microscopy, verdin, in the course of which iron is released and carbonand the TUNEL method.
monoxide is emitted; biliverdin is subsequently con-Results. HO-1 overexpressing LLC-PK1 cells demonstrated
verted to bilirubin by the enzyme biliverdin reductasecellular hypertrophy, decreased hyperplastic growth, and growth
arrest in the G0/G1 phase of the cell cycle. HO-1 overexpressing [1–3]. Of the three enzymes which possess HO activity,
cells were markedly resistant to apoptosis induced by TNF/ HO-1 is the isoform that responds rapidly and robustly
cycloheximide or staurosporine as assessed by the caspase-3 to diverse stimuli [1–3]; and remarkably, in numerousactivity assay. Such overexpression also conferred resistance
instances in which it is induced, HO-1 protects tissuesto apoptosis induced by serum deprivation as evaluated by the
against a wide range of insults including those that areTUNEL method; in these studies, inhibition of HO attenuated
the resistance to apoptosis. Expression of the cyclin dependent nephrotoxic [4–6], hypoxic [7], hyperoxic [8], hemody-
kinase inhibitor, p21CIP1, WAF1, SDI1, as judged by Northern and namic [9], ischemic [10], inflammatory [11], and trans-
Western analyses, was significantly increased in HO-1 overex- plant-related in origin [12].pressing cells, and decreased as HO activity was inhibited.
The basis for this commonly observed protective effectMoreover, this reduction in expression of p21 attendant upon
of induced HO-1 rests on actions of this enzyme, whichthe inhibition of HO activity in HO-1 overexpressing cells
paralleled the loss of resistance of these cells to apoptosis when singly or in unison, can interrupt these pathways of injury
HO activity is inhibited. The pharmacologic inducer of HO-1, [1–3]. For example, the induction of HO-1 guards against
hemin, increased expression of p21 in wild-type cells and de- the buildup in injured tissue of heme which, in largecreased apoptosis provoked by TNF-/cycloheximide.
amounts, is a prooxidant species [13]; in states of tissueConclusion. Cellular overexpression of HO-1 up-regulates
injury, destabilized heme proteins may release their hemep21, diminishes proliferative cell growth, and confers marked
resistance to apoptosis. We speculate that such up-regulation prosthetic group thereby providing copious amounts of
of p21 contributes to the altered pattern of cell growth and this potentially toxic species. HO-1 generates carbon
resistance to apoptosis. Our studies uncover the capacity of monoxide, a gaseous product that is vasodilatory, anti-
apoptotic, and anti-inflammatory [14–17]. Anti-inflam-
matory actions arise not only from carbon monoxide,Key words: LLC-PK1, apoptosis, cell growth, cytoprotectant, nephro-
toxicity, hypoxia, inflammation, tissue injury. but also from biliverdin and bilirubin [18, 19]. These bile
pigments, additionally, possess antioxidant and cytopro-Received for publication May 7, 2001
tective properties [20, 21]. The induction of HO-1 alsoand in revised form July 3, 2001
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cells or transferring iron out of cells, may minimize the Gaithersburg, MD, USA) supplemented with 10% fetal
calf serum (FCS), 100 U/mL penicillin, 100 g/mL strep-risk for iron-catalyzed oxidant stress and attendant cellu-
lar injury [22–24]. tomycin and 20 mmol/L HEPES, as described previously
[34, 35]. HO-1 overexpressing LLC-PK1 cells were cul-Whether such effects accruing from the induction of
HO-1—the removal of a prooxidant species (heme) and tured in a similar medium except for the addition of
100 g/mL G418 and glucose at a concentration ofthe elaboration of putative cytoprotectants (carbon mon-
oxide, bile pigments, iron-handling proteins)—account 4.5 g/L. In some studies LLC-PK1 cells were exposed to
hemin (iron protoporphyrin IX) or zinc protoporphyrin;for the full measure of the beneficial effects of HO-1 is
an unresolved issue [1–3]. Indeed, there is a sense that concentrated stocks of these solutions were freshly made
in 0.05 N sodium hydroxide and used to achieve the finalas-yet-undefined mechanisms elicited by HO-1 may con-
tribute to its cytoprotective effects [1–3]. Moreover, each concentration by appropriate dilution with serum-free
incubation media.product of HO in a given circumstance can inflict tissue
injury [25], and there are clearly defined settings, includ-
HO-1 overexpression in LLC-PK1 cellsing those involving the kidney, wherein the induction of
HO-1 exacerbates, rather than retards, tissue damage LLC-PK1 cells were stably transfected with either an
empty expression vector (control cells) or a plasmid con-[26–28]. Thus, beneficial effects may not arise from HO-1
induced in injured tissue; and if protective effects are taining the rat HO-1 cDNA driven by the Friend spleen
focus-forming virus long terminal repeat (HO-1 overex-observed following such induction, they may not neces-
sarily be channeled through mechanisms conventionally pressor) by methods previously described in detail [36].
Transfectants were selected in G418, and individualinvoked for the salutary actions of HO-1. In this regard,
the exploration of the cellular effects that result from clones were isolated by limited dilution. HO-1 transgene
expression was confirmed by Northern and Westernthe up-regulation of HO-1 is of interest, as is the uncov-
ering of hitherto unsuspected pathways recruited by analyses, and by measurement of HO activity. In some
studies with HO-1 overexpressing cells, incubation withHO-1 as it safeguards against tissue injury.
Employing an approach in which we genetically engi- zinc protoporphyrin (10 mol/L) in serum-free medium
for 12 hours was employed to inhibit HO activity. Inneered a widely utilized renal tubular epithelial cell line,
LLC-PK1 cells, to exhibit stable overexpression of HO-1, studies evaluating the sensitivity to apoptosis in HO-1
overexpressing and control cells, cells were examined byour present study explored the effect of up-regulation
of HO-1 in renal epithelial cells, initially with the intent phase contrast microscopy for the manifestation of such
features of apoptosis as cellular shrinkage, granularity,of examining the effect of such overexpression on suscep-
tibility to apoptosis. In the course of these studies we and membrane blebbing.
encountered a profound effect of overexpression of HO-1
Determination of expression of HO-1 and p21 mRNAon cellular growth. Our attention was drawn to this find-
and protein in LLC-PK1 cellsing, since cell fate in renal and extrarenal tissues is
strongly determined by cell growth and cell cycle-related Northern and Western analyses were performed by
methods described in detail by prior publications fromevents [29–31]. For example, the absence of cyclin depen-
dent kinase inhibitors such as p21 and p27—species that this laboratory [37]. Extraction of RNA from cultured
cells was performed using the Trizol method (Life Tech-interrupt the cell cycle—exaggerates apoptosis in murine
models of acute glomerular and tubular injury [32, 33]. nologies, Gaithersburg, MD, USA). Ten microgram sam-
ples of total RNA were separated on agarose gels andWe thus examined in these HO-1 overexpressing cells
their progression through the cell cycle, and expression transferred to nylon membranes. Membranes were hy-
bridized with a mouse HO-1 cDNA or a human p21of these cell cycle regulators. Our finding that increased
expression of HO-1 in renal epithelial cells markedly cDNA probe that had been 32P-labeled [37]. Autoradio-
grams were evaluated for loading and transfer, as pre-influences cell growth and the cell cycle uncovers a po-
tential, and heretofore unsuspected, mechanism by which viously described [37], by assessing the optical density
of the 18S rRNA on an ethidium bromide-stained nylonHO-1 may confer resistance of renal epithelial cells to
injury. membrane.
Western analysis for HO-1 and p21 was performed on
protein extracted from these cultures using the Trizol
METHODS
method (Life Technologies). Briefly, samples containing
Cell culture studies 100 g of protein were separated on 15% Tris-HCl gels,
and were transferred to PVDF membranes (Bio-RadAll reagents employed were obtained from Sigma
(Sigma, St. Louis, MO, USA) unless otherwise stated. Laboratories, Hercules, CA, USA). For analysis of ex-
pression of HO-1 protein, a rabbit, anti-rat, polyclonalLLC-PK1 cells (American Type Culture Collection, Rock-
ville, MD, USA) were cultured in DMEM (Gibco-BRL, HO-1 antibody was employed (SPA895, StressGen Bio-
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technologies, Victoria, BC, Canada) followed by a horse- which 1.5 mL of 95% ethanol was added dropwise over
one minute. Following incubation at room temperatureradish peroxidase-conjugated goat, anti-rabbit IgG anti-
body (SAB 300, StressGen Biotechnologies) for a second- for five minutes and washing, cells were incubated with
180 g/mL of RNase A for 30 minutes at 37C andary antibody. Rat HO-1 (Rat HSP 32, SPP 730; StressGen
Biotechnologies) was used as a positive control. Expres- washed once in culture medium. Immediately before
analysis, cells were incubated with propidium iodidesion of p21 protein was analyzed using a mouse anti-p21
monoclonal antibody (65961A; Pharmingen, San Diego, (20g/mL) in the dark for 20 minutes on ice. Flow cytome-
try was performed on a Becton Dickinson FACScanCA, USA) as the primary antibody and a polyclonal
goat, anti-mouse IgG antibody (M15345; Transduction (San Jose, CA, USA) using an excitation wavelength of
488 nm and emission wavelength of 585 nm; ModFitLabs, Lexington, KY, USA) as the secondary antibody.
Protein from a cellular extract of MCF-7 cells was used software (Verity Software House, Topsham, ME, USA)
was employed in the analysis of data [40].as a p21 positive control. Detection was achieved by
using a chemiluminescence method (Amersham Phar-
Assessment of apoptosismacia Biotech, Piscataway, NJ, USA).
Quantitation of caspase-3 activity. Apoptosis was in-
Measurement of HO activity duced in confluent monolayers of LLC-PK1 cells by in-
cubation with either TNF- (2 or 5 ng/mL, PHC3015;Heme oxygenase activity was measured in microsomal
preparations from HO-1 overexpressing and control cells Biosource International, Camarillo, CA, USA) in con-
junction with cycloheximide (10 g/mL), or staurosporineby the determination of the generation of bilirubin by
microsomes, as described in our prior studies [37]. (1 mol/L) for two to three hours depending upon the
study. In certain protocols, HO-1 was induced in LLC-
Determination of protein/DNA content PK1 cells by exposure to hemin (10 mol/L) in serum-
free medium for four hours prior to the induction ofProtein and DNA determinations were performed on
whole homogenates prepared from HO-1 overexpressing apoptosis. Apoptosis was assessed by determining casp-
ase-3 proteolytic activity by a fluorometric method thatand control cells. Protein content was assayed using the
Lowry method. DNA content was determined using a is now widely established as a quantitative assay for apo-
ptosis [41, 42]. This assay determines the liberation of themodification of the method of Burton as previously per-
formed by our laboratory [38, 39]. Briefly, cells were fluorochrome 7-amino-4-trifluoromethyl coumarin (AFC)
from a fluorogenic substrate, Z-DEVD-AFC. Monolay-scraped from 10 cm culture dishes in a 0.1 mol/L potas-
sium phosphate lysis buffer and homogenized on ice. ers of cells which had been incubated with or without
apoptotic agents were washed once with PBS and thenAfter washing with 0.2 N perchloric acid, the pellet was
resuspended in 0.5 N perchloric acid, hydrolyzed at 85C, lysed on ice with a 25 mmol/L HEPES buffer (pH 7.5)
containing 5 mm MgCl2, 5 mmol/L ethylenediaminetetra-and the sample then centrifuged at 1500  g for 15
minutes. Extracted DNA in the supernatant was incu- acetic acid (EDTA), 1 mmol/L egtazic acid (EGTA), 2
mmol/L phenylmethylsulfonyl fluoride (PMSF), 10 g/mLbated in a reaction mixture consisting of 5% perchlorate,
20 mg/mL diphenylamine, 40 g/mL acetaldehyde and pepstatin, 10 g/mL leupeptin, 1 g/mL aprotinin, and
5 mmol/L dithiothreitol (DTT). Lysates were then centri-50% acetic acid overnight at 37C. Cell DNA concentra-
tions were determined spectrophotometrically at 595 nm fuged for three minutes at 20,000  g and the superna-
tant assayed for caspase-3 activity. Five to 50 g of cy-and standardized against a calibration curve constructed
using calf thymus DNA. tosolic protein was incubated in a reaction mixture
containing 100 mmol/L HEPES (pH 7.5), 10% sucrose,
Assessment of proliferative cell growth 0.1% CHAPS, 10 mmol/L DTT, and 50 mol/L fluoro-
genic caspase-3 substrate, DEVD-AFC (Calbiochem,To determine the effect of HO-1 on proliferative cell
growth, HO-1 overexpressing and control cells were San Diego, CA, USA) for one hour at 37C. To ensure
specificity of the assay for caspase-3 activity, each sampleplated in six well culture dishes at an initial density of
5  104 cells per well. At daily intervals, cells were tryp- was assayed in the presence or absence of a caspase-3
inhibitor, Ac-DEVD-CHO (20 mol/L; Calbiochem)sinized and counted using a hemacytometer.
and the difference of fluorescence between the two sam-
Fluorescence-activated cell sorter analysis ples was standardized against a calibration curve of free
AFC. Reactions were performed in 100 L volumes onCell cycle analysis was performed by fluorescence-
activated cell sorter analysis (FACS). Approximately 2 96 well plates and the resulting fluorescence was mea-
sured using a FL600 Microplate Fluorescence Reader106 HO-1 overexpressing cells and control cells were
harvested by trypsinization and gently pelleted by cen- (Bio-Tek Instruments, Winooski, VT, USA) fitted with
filters allowing excitation at 400 nm and detection oftrifugation at 200 g for five minutes. Cells were washed
in cold PBS and then resuspended in 0.5 mL of PBS, to emission at 505 nm. Caspase-3 activity was standardized
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for protein in the supernatant, the latter determined by
the Lowry method.
TUNEL method. The TUNEL assay was used to eval-
uate apoptosis in HO-1 overexpressing and control cells
subjected to TNF-/cycloheximide, and under conditions
in which cells were exposed to deprivation of serum in
the cell culture medium. In studies involving deprivation
of serum in the cell incubation medium, cells were seeded
into six well plates, grown to confluence, and incubated
in the presence (standard culture medium) or absence
of FCS for 36 hours. During the last 12 hours of this
incubation, serum-deprived cells were incubated in the
presence or absence of zinc protoporphyrin (10 mol/L).
Following these incubations, cells that had detached
from the monolayers were collected by gentle centrifuga-
tion of the incubation medium for each well and com-
bined with cells subsequently harvested by trypsinization
from the bottom of the wells. The resulting cell pellets
were washed once with PBS and fixed by resuspension
in 0.5 mL methanol-free formaldehyde (1% in PBS;
Polysciences Inc., Warrington, PA, USA) for 15 minutes
at room temperature. Fifty microliters of these cell sus- Fig. 1. Assessment of heme oxygenase (HO) activity (A), expression
of HO-1 protein by Western analysis (B), and expression of HO-1pensions were then dried onto glass microscope slides
mRNA by Northern analysis (C) in control () and HO-1 overexpress-that had previously been coated with a 0.1% poly- ing (HO-1 OE, ) LLC-PK1 cells. In studies of HO activity (A), N 
l-lysine solution (Polysciences, Inc.). Apoptosis was de- 4 in each group, and *P  0.05 between control and HO-1 overexpress-
ing cells.tected in these cell preparations using the Apoptag Plus
Peroxidase In Situ Apoptosis Detection Kit (Intergen,
Purchase, NY, USA), as previously described [43]. This
method detects DNA fragmentation associated with Figure 1. As demonstrated, HO-1 mRNA and protein
apoptosis by labeling of 3-OH DNA termini with digoxi- are markedly increased in these cells, and are accompa-
genin-nucleotides, a process facilitated by terminal deox- nied by a fivefold increase in HO activity.
ynucleotidyl transferase (TdT); these labeled fragments In these HO-1 overexpressing cells, a profoundly altered
are then allowed to bind to an anti-digoxigenin antibody pattern of cellular growth is observed, and is character-
conjugated with peroxidase, and DAB is then used as the ized by enhanced hypertrophic cell growth but dimin-
substrate for the peroxidase. A sham incubation (without ished hyperplastic growth. As evidence of hypertrophy
TdT) was performed for each cell preparation as a nega- in HO-1 overexpressing cells, the protein/DNA ratio is
tive control. In studies of apoptosis induced by serum significantly increased in these cells as compared to con-
deprivation and assessed by the TUNEL assay, apoptotic trol cells (19.7  0.8 vs 26.2  1.3, N  5, P  0.05).
cells were counted in four separate fields examined for Hyperplastic (proliferative) cell growth was clearly di-
each of these six conditions; the number of apoptotic minished as indicated in studies involving daily enumera-
cells was expressed as a percent of the total number of tion of cells following the plating of identical numbers
of HO-1 overexpressing and control cells (Fig. 2). Aftercells in each field, and the mean value determined for
initial plating of 5  104 cells per well of either HO-1these four fields in each of these six conditions.
overexpressing or control cells, there were half as many
Statistics HO-1 overexpressing cells by day 3, and this diminished
proliferative growth of HO-1 overexpressing cells per-Data are expressed as means  SEM and are consid-
sisted over the period of study (Fig. 2).ered statistically significant for P 0.05. For comparison
To analyze further the pattern of growth of HO-1between unpaired groups, the Student t test or the Mann-
overexpressing cells, cell cycle analysis was conductedWhitney was employed as appropriate.
using FACS. As shown in Figure 3, the numbers of HO-1
overexpressing cells as compared to control cells were
RESULTS increased in the G0/G1 phase and diminished in the
Analyses pertaining to the expression of HO-1 in ge- S/G2/M phases. Thus, HO-1 overexpressing cells exhibit
growth arrest in the G0/G1 phase of the cell cycle.netically altered and control cells are summarized in
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Fig. 2. Enumeration of control () and HO-1 overexpressing () LLC- Fig. 3. Cell cycle analysis by fluorescence activated cell sorter analysis
PK1 cells on sequential days after initially plating equal numbers of cells in control () and HO-1 overexpressing () LLC-PK1 cells. Data are
on day 0. N  6 in control and HO-1 overexpressing cells; *P  0.05 expressed as the percentage of cells in the G0 and G1 phases (G0/G1)between control and HO-1 overexpressing LLC-PK1 cells on that day. and percentage of cells in the S, G2, and M phases of the cell cycle
(S/G2/M). N  4 in control and HO-1 overexpressing cells; *P  0.05
between control and HO-1 overexpressing cells.
To determine whether overexpression of HO-1 influ-
enced vulnerability to apoptosis, we evaluated apoptotic
evaluated the specificity of HO activity in accounting forresponses in these cells using three different assays and
the resistance to apoptosis in HO-1 overexpressing cellsthree different pro-apoptotic stimuli. Figure 4 presents
by examining the effect of the competitive inhibitor ofdata from studies in which apoptosis was induced by two
HO, zinc protoporphyrin. Representative findings fromdistinct stimuli (TNF- in conjunction with cyclohexi-
these studies are shown in Figure 6. With serum depriva-mide, and staurosporine) that utilize different proximate
tion, control cells exhibited apoptosis (Fig. 6, B vs. A),pathways in the induction of apoptosis; in these studies,
and the concomitant presence of zinc protoporphyrinapoptosis was assessed by a quantitative assay based
increased the severity of apoptosis in these cells (Fig. 6,on the spectrofluorometric determination of caspase-3
C vs. B). The percent of apoptotic cells under conditionsactivity. As demonstrated, HO-1 overexpressing cells
represented by Figure 6 A, B, and C were 0, 37  3,were resistant to apoptosis induced either by TNF-
and 60  8%, respectively. HO-1 overexpressing cellsand cycloheximide (Fig. 4A) or staurosporine (Fig. 4B).
were strikingly resistant to apoptosis induced by serumMorphologic examination of these cells by phase con-
deprivation (Fig. 6, E vs. D, E vs. B). This resistance totrast microscopy also demonstrated that HO-1 overex-
apoptosis in HO-1 overexpressing cells was attenuatedpressing cells were resistant to these pro-apoptotic
by the inhibitor of HO activity, zinc protoporphyrinagents, TNF-/cycloheximide and staurosporine: such
(Fig. 6, F vs. E). The percent of apoptotic cells underfeatures as cellular shrinkage, granularity, and mem-
conditions represented by Figure 6 D, E, and F were 0,brane blebbing were prominent in control cells exposed
0, and 18  2%, respectively. These studies thus under-to TNF-/cycloheximide, or staurosporine, but were in-
score the specific contribution of HO activity to the resis-conspicuous in HO-1 overexpressing cells so exposed.
tance observed in HO-1 overexpressing cells. This resis-This resistance of HO-1 overexpressing cells to apo-
tance of HO-1 overexpressing cells to apoptosis inducedptosis was again demonstrable by another technique, the
by serum deprivation and assessed by the TUNEL assay,TUNEL assay, in studies that utilized TNF-/cyclohexi-
and the attenuation of this resistance by zinc protopor-mide as the pro-apoptotic insult. These data are shown in
phyrin, were corroborated by morphologic examinationFigure 5. Control cells demonstrate prominent apoptosis
of HO-1 overexpressing and control cells by phase con-following exposure to TNF-/cycloheximide (Fig. 5, B
trast microscopy under these conditions.vs. A). In striking contrast, HO-1 overexpressing cells,
Overexpression of HO-1 in LLC-PK1 cells thus is at-when subjected to TNF-/cycloheximide under these
tended by growth arrest in the G0/G1 phase of the cellidentical conditions, were markedly resistant to apopto-
cycle and resistance to apoptosis. To explore a possiblesis (Fig. 5, D vs. C, and D vs. B).
mechanism that may account for these changes, the ex-To examine this resistance to apoptosis in HO-1 over-
pression of cyclin-dependent kinase inhibitors was exam-expressing cells further, apoptosis was assessed in these
ined, in particular, p21, as p21 possesses the dual capabili-cells by the TUNEL assay, and in response to the pro-
apoptotic insult, serum deprivation. These studies also ties of inducing cell cycle arrest (in the G0/G1 phase) and
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Fig. 4. Assessment by the caspase-3 activity
assay of apoptosis induced by TNF/cyclohex-
imide (A) or staurosporine (B) in control ()
and HO-1 overexpressing (HO-1 OE, )
LLC-PK1 cells. Data presented in the left
panel were derived from studies that involved
exposure to TNF for 3 hours and at a concen-
tration of 5 ng/mL. N  6 in control and
HO-1 overexpressing LLC-PK1 cells; *P 
0.05 between control and HO-1 overexpress-
ing cells.
conferring resistance to apoptosis (Discussion section). to pro-apoptotic stimuli: HO-1 overexpressing cells ex-
As demonstrated in Figure 7, p21 mRNA and protein hibited diminished hyperplastic growth, growth arrest in
were both significantly increased in HO-1 overexpressing the G0/G1 phase of the cell cycle, and resistance to apo-
cells. In contrast, the cyclin-dependent kinase inhibitor, ptosis, the latter induced either by TNF-/cyclohexi-
p27, was not induced in these cells (data not shown). mide, staurosporine, or serum deprivation. We con-
To determine if a causal relationship exists between firmed in these HO-1 overexpressing cells that HO activ-
the expression of HO-1 in HO-1 overexpressing cells and ity per se contributed to this resistance to apoptosis: the
the up-regulation of p21 in these cells, we examined whe- inhibition of HO activity attenuated the resistance to
ther the inhibition of HO activity by zinc protoporphyrin apoptosis when the latter was induced by serum with-
in these cells altered the expression of p21 protein. These drawal.
studies were performed under conditions that repro- To examine possible mechanisms that may account
duced those in which zinc protoporphyrin was employed for this induction of hypertrophy and the conferment of
in the later phase of serum deprivation and apoptosis resistance to apoptosis, we considered molecular signals
assessed, as described in Figure 6. As demonstrated in that may exert these dual actions. In this regard, p21, a
Figure 8, the exposure of HO-1 overexpressing cells to cyclin dependent kinase inhibitor that promotes cellular
the inhibitor of HO activity, zinc protoporphyrin, led to hypertrophy and enables cells to resist apoptosis [29, 31,
significant down-regulation of p21. 44], was chosen as a possible candidate. p21 mRNA and
We then questioned whether up-regulation of HO-1 protein were significantly up-regulated in HO-1 overex-
by an alternative approach besides transfection of cells pressing cells. That HO activity per se contributed to such
with the rat HO-1 gene would also induce p21. To this increased expression of p21 was demonstrated in studies
end, we employed a recognized and widely employed in which such activity of HO was inhibited in HO-1
chemical inducer of HO-1, namely, hemin [1, 2]. We overexpressing cells. Moreover, this reduction in expres-
confirmed that wild-type LLC-PK1 cells exposed to he- sion of p21 in HO-1 overexpressing cells exactly paral-
min demonstrate increased expression of HO-1 (data leled the loss of resistance of these cells to apoptosis
not shown). Concomitant with this, wild-type LLC-PK1 when HO activity is inhibited. Finally, in complementary
cells exposed to hemin exhibited increased expression
studies using a pharmacologic inducer of HO-1 (hemin)
of p21 mRNA and increased p21 protein (Fig. 9). Such
in wild-type cells, induction of HO-1 was accompanied by
pharmacologic induction of HO-1 was functionally sig-
increased expression of p21 and resistance to apoptosis.nificant: under these conditions in which the prior expo-
These studies thus provide the novel demonstration thatsure of LLC-PK1 cells to hemin led to an up-regulation
induction of HO-1 by genetic or pharmacologic ap-of HO-1 and increased expression of p21, a significant
proaches induces expression of p21. The mechanisms byresistance to apoptosis, induced by TNF-/cyclohexi-
which cellular expression of HO-1 influences that of p21mide, also was observed (Fig. 10).
merit further study. It is possible that the immediate
end products of HO activity (iron, bile pigments, carbon
DISCUSSION monoxide) or more distal effects of HO activity may
up-regulate cellular expression of p21, and studies thatIn our analysis of LLC-PK1 cells stably transfected
explore such involvement represent relevant and impor-with rat HO-1 cDNA, we confirmed the efficacy of trans-
tant areas of investigation.fection as demonstrated by markedly increased HO-1
The resistance of HO-1 overexpressing cells to apopto-mRNA and protein, and robustly increased HO activity.
sis was particularly striking (Figs. 4, 5, and 6), and wasSuch overexpression of HO-1 profoundly altered cellular
behavior as assessed by patterns of growth and sensitivity displayed against three different pro-apoptotic insults.
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Fig. 5. Cells studied by the TUNEL method
(magnification 400). (A) Control cells ex-
posed to culture media for 3 hours prior to
harvesting of cells for TUNEL staining. (B)
Control cells exposed to culture media con-
taining TNF- (2 ng/mL)/cycloheximide for 3
hours prior to harvesting of cells for TUNEL
staining. (C) HO-1 overexpressing cells ex-
posed to culture media for 3 hours prior to
harvesting of cells for TUNEL staining. (D)
HO-1 overexpressing cells exposed to culture
media containing TNF- (2 ng/mL)/cyclohexi-
mide for 3 hours prior to harvesting of cells
for TUNEL staining.
Fig. 6. Control cells (A-C ) and HO-1 overex-
pressing cells (D-F ), studied by the TUNEL
method (magnification 400). (A) Control
cells maintained under standard cell culture
(serum-containing medium) conditions prior
to harvesting of cells for TUNEL staining.
(B) Control cells maintained under serum-
deprived medium for 36 hours prior to harvest-
ing of cells for TUNEL staining. (C) Control
cells maintained for 36 hours under serum-
deprived medium which contained zinc proto-
porphyrin (10 mol/L) for the final 12 hours
preceding harvest of cells for TUNEL stain-
ing. (D) HO-1 overexpressing cells maintained
under standard cell culture (serum-containing
medium) conditions prior to harvesting of cells
for TUNEL staining. (E) HO-1 overexpressing
cells maintained under serum-deprived medium
for 36 hours prior to harvesting of cells for
TUNEL staining. (F) HO-1 overexpressing
cells maintained for 36 hours under serum-
deprived medium which contained zinc proto-
porphyrin (10 mol/L) for the final 12 hours
preceding harvest of cells for TUNEL staining.
Notably, the specificity of HO activity in contributing to with serum deprivation (Fig. 6, F vs. E). In such studies
of serum deprivation, however, the severity of apoptosisthis resistance was confirmed in studies of HO-1 overex-
pressing cells in which the specific competitive inhibitor was not as marked as apoptosis observed in control cells
subjected to HO inhibition in conjunction with serumof HO (zinc protoporphyrin) was applied in conjunction
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Fig. 7. Expression of p21 mRNA by Northern analysis (A) and p21
protein by Western analysis (B) in control and HO-1 overexpressing
cells (HO-1 OE) LLC-PK1 cells maintained under standard cell culture Fig. 9. Induction of p21 mRNA by Northern analysis (A) and p21
(serum-containing medium) conditions. The plus symbol represents the protein by Western analysis (B) in wild-type LLC-PK1 exposed to
positive control as described in the Methods section. hemin (10 mol/L). The plus sign represents the positive control as
described in the Methods section.
Fig. 8. Expression of HO-1 protein (A) and p21 protein (B) by Western
analysis in control and HO-1 overexpressing (HO-1 OE) LLC-PK1
cells subjected to zinc protoporphyrin (ZnPP, 10 mol/L) or vehicle
(Veh) under serum-deprived conditions, as summarized in the legend
to Figure 6. Fig. 10. Protective effect of prior exposure to hemin in wild-type LLC-
PK1 cells subjected to apoptosis induced by TNF-/cycloheximide and
assessed by the caspase-3 activity assay. Data presented are derived
from studies that involved exposure to TNF- for 2 hours and at a
concentration of 2 ng/mL. N  6 in control and hemin-treated LLC-deprivation (Fig. 6, F vs. C). The explanation for these
PK1 cells; *P  0.05 between control and hemin-treated cells.findings may reside in the less than complete inhibition
of HO activity by zinc protoporphyrin in HO-1 overex-
pressing cells, the latter demonstrating a particularly vig-
orous augmentation in HO activity. Indeed, to the extent a mechanism through which pathophysiologically rele-
vant stimuli promote such renal growth is supported bythat increased expression of p21 accounts for the resis-
tance of HO-1 overexpressing cells to apoptosis, it is not- substantial literature. For example, LLC-PK1 cells trans-
fected with adenoviral vectors containing coding se-able that inhibition of HO in these cells clearly reduced,
but did not ablate, cellular expression of p21 (Fig. 8). quences of p21 exhibit increased protein synthesis, in-
creased protein/DNA content, and increased cell size onWe speculate that this resistance to apoptosis in HO-1
overexpressing cells may reflect the up-regulation of p21 FACS analysis [45]. Angiotensin II, a recognized inducer
of hypertrophy in renal tubular epithelial cells [46], sig-that occurs in these cells, and that the anti-apoptotic
effects of p21 may contribute to, or synergize with, the nificantly up-regulates p21 [45], thereby raising the possi-
bility that p21 may assist in angiotensin II-induced hyper-anti-apoptotic actions of HO-1 in these HO-1 overex-
pressing cells. However, the involvement of p21 in this trophy. p21	/	mice subjected to streptozotocin-induced
diabetes mellitus fail to evince the expected glomerularresistance to apoptosis in HO-1 overexpressing cells re-
quires evaluation by studies in which the expression hypertrophy that occurs in diabetic nephropathy [47].
Consonant findings are observed in the renal ablationand/or actions of p21 are inhibited and sensitivity to
apoptosis concomitantly evaluated. model [48]: mice deficient in p21, when subjected to
subtotal reduction of renal mass, evince a hyperprolifera-That p21 induces renal hypertrophy and may serve as
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tive rather than a hypertrophic response, the latter more sis [32]. Interestingly, induction of HO-1 occurs in re-
sponse to such nephrotoxins as cisplatin in vivo and inemblematic of the changes in the kidney following subto-
tal renal ablation in wild-type (p21
/
) mice [48]. Thus, vitro; such induction of HO-1 is functionally significant
since inhibition of HO worsens renal injury induced byample evidence, derived from in vitro and in vivo set-
tings, supports the view that p21 can induce renal hyper- cisplatin [5], while HO-1	/	 mice exhibit heightened
renal damage, both structurally as well as functionally,trophy.
p21 protects against apoptosis in numerous cell types in response to cisplatin [6]. Moreover, human proximal
tubular epithelial cells that overexpress HO-1 are resis-and in response to diverse pro-apoptotic stimuli. Overex-
pression of p53 in colorectal cancer cells, for example, tant to the toxicity of cisplatin in vitro [6]. Based on our
findings, we speculate that the mechanisms by whichcan induce either growth arrest or apoptosis; increased
expression of p21 accompanies the growth-arrest re- induction of HO-1 protects against cisplatin-induced
nephrotoxicity involve p21-dependent mechanisms. Thissponse in these cells, and the homologous deletion of
p21 leads to apoptosis rather than a growth arrest re- linkage also may be relevant to other types of toxic
nephropathy such as myoglobin-induced renal injury; forsponse when p53 is overexpressed [49]. Overexpression
of p21 protects human melanoma cells against p53-driven example, myoglobin, a heme protein and a recognized
inducer of HO-1, was previously shown to inhibit theapoptosis [50]; similarly, overexpression of p21 safe-
guards human colorectal carcinoma cells against prosta- proliferation of renal tubular epithelial cells [58]. It is
possible that such growth arrest may reflect inductionglandin A2-mediated apoptosis [51]. Fibroblasts defi-
cient in p21, as compared to wild-type fibroblasts, are by HO-1 by myoglobin, and attendant up-regulation of
p21. Interestingly, HO-1 overexpressing pulmonary epi-more sensitive to p53-driven apoptosis [50]. Induction
of p21 accompanies differentiation of certain cell types thelial cells are resistant to hyperoxia and exhibit growth
arrest; we suggest that induction of p21 may also bein vitro, and such expression of p21 confers resistance
to apoptosis that can occur with differentiation [52, 53]. germane to these hitherto unexplained findings [36].
That the expression of p21 is linked to HO-1 also mayRelevant to this latter finding is the recent demonstration
that nuclear factor-B (NF-B)-dependent up-regula- be relevant to the pathogenesis of chronic renal injury
from at least three perspectives. The first pertains to thetion of p21 forestalls monocytes from undergoing apo-
ptosis as these cells differentiate [54]. exaggeration of renal injury observed in p21	/	 mice.
For example, in response to anti-glomerular basementThe anti-apoptotic effect of p21 stems from its ability
to promote arrest of the cell cycle per se as well as actions membrane (anti-GBM) disease p21	/	 mice demon-
strate markedly increased visceral glomerular epithelialof p21 that interrupt the effector pathways for apoptosis.
The induction of cell cycle arrest facilitates the repair of cell proliferation, increased numbers of cells undergoing
apoptosis, increased matrix accumulation, and decreaseddamaged DNA, while the interruption of progression
through the cell cycle prevents the replication of dam- renal function [59]. The induction of HO-1 occurs in
anti-GBM disease and confers a protective role [60],aged DNA [29, 31, 44]. Thus, p21-induced cell cycle
arrest—a property dependent on inhibition of cyclin de- findings that raise the possibility that HO may confer such
protection through the induction of p21. In tubulointer-pendent kinase—is anti-apoptotic to the extent that it
proscribes the persistence or replication of damaged stitial disease induced by ureteric obstruction, p21	/	
mice demonstrate significantly increased interstitial cellDNA. In addition to these anti-apoptotic effects of p21
arising from its capacity to induce cell cycle arrest, p21 proliferation and increased myofibroblast accumulation
[61]. Urinary tract obstruction induces HO-1, again pro-may confer resistance to apoptosis by mechanisms di-
rectly influencing the effector mechanisms for apoptosis. viding another circumstance wherein the linkage of
HO-1 and p21 may be relevant [62]. An additional per-For example, p21 can inhibit the proximal events in apo-
ptosis by virtue of its inhibitory effects on initiator cas- spective is raised by the fact that angiotensin II and
transforming growth factor 1 (TGF-1) can, indepen-pases, namely, caspase-8 and caspase-10 [55]. p21 can
bind to procaspase-3 and thereby prevent the activation dently, induce p21 [31], and as recently recognized, either
angiotensin II or TGF-1 can induce HO-1 [63, 64]. Itof caspase-3, the latter representing a pivotal member of
executioner caspases [56]. p21 also binds to, and thereby is possible that induction of HO-1 by angiotensin II or
TGF-1 accounts for the up-regulation of p21, therebyvitiates, pro-apoptotic signals such as apoptosis signal-
regulating kinase-1 (ASK-1) in monocytes undergoing providing a countervailing response that opposes the
injurious actions of angiotensin II and TGF-1 in thedifferentiation [57].
p21 confers resistance to apoptosis in the kidney as kidney. Finally, our observations are germane to quite
recent studies in a model of arterial injury wherein ex-indicated by seminal studies in p21	/	 mice [32]. When
subjected to the nephrotoxic chemotherapeutic agent, pression of HO-1 diminishes proliferative changes and
damage in the vasculature through pathways that likelycisplatin, p21	/	 mice demonstrate greater deteriora-
tion of renal function and much more abundant apopto- involve up-regulation of p21 [65].
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